Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 30, 743-752, March 1, 1970]
© 1970 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Endo, H.
Right arrow Articles by Yanagi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Endo, H.
Right arrow Articles by Yanagi, S.

Irreversible Fixation of Increased Level of Muscle Type Aldolase1 Activity Appearing in Rat Liver in the Early Stage of Hepatocarcinogenesis,2

Hideya Endo, Masao Eguchi3 and Susumu Yanagi

Cancer Research Institute, Faculty of Medicine, Kyushu University, Fukuoka, Japan

With the use of antimuscle aldolase sera, muscle type aldolase activity in the liver of adult rats was determined during a 60-day interval after stopping the administration of a diet containing 0.06% 3'-methyl-4-dimethylaminoazobenzene for 60 days.

The muscle type aldolase in the livers of rats thus treated was found to be elevated when compared to normal liver, although no appreciable differences were observed in total aldolase activity, mitotic index, histological architecture, and soluble protein, as well as DNA content.

The appearance of this enzymic change was already observable by administrating the azo dye only for 15 days.

The increased level of muscle type aldolase activity observed in the liver of rats fed azo dye for 60 days was maintained during a 300-day observation period.

A similar enzymic alteration could be induced by another hepatocarcinogen, N,N'-2,7-fluorenylenebisacetamide, whereas a noncarcinogen, 2-methyl-4-dimethylaminoazobenzene, failed to induce this change.

1 In this paper we tentatively defined the liver enzyme neutralizable with antimuscle aldolase sera as "muscle type aldolase," distinguished from muscle aldolase, since the identity of both enzymes is not yet conclusively determined.

2 This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Japan.

3 Present address: Department of Orthopaedy, Faculty of Medicine, Kyushu University, Fukuoku, Japan.

Received 5/19/69. Accepted 8/19/69.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1970 by the American Association for Cancer Research.